Research output per year
Research output per year
Personal profile
Research interests
Site specific drug delivery to the colon, mucus turnover and influence on drug absorption, mucoadhesive formulations, novel penetration enhancers, drug delivery to the lungs, dermal drug delivery.
Research interests (short)
Drug delivery to the lungs, skin and colon.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Gary Martin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A study of solid-state epimerisation within lactose powders and implications for milk derived ingredients stored in simulated tropical environmental zones
Alzoubi, T., Martin, G. P. & Royall, P. G., 15 Feb 2023, In: FOOD CHEMISTRY. 402, 134206.Research output: Contribution to journal › Article › peer-review
Open Access4 Citations (Scopus) -
Repurposing Melt Degradation for the Evaluation of Mixed Amorphous-Crystalline Blends
Abdul-jabbar, S., Wong, D. W., Martin, G. P., Woodhead, B. & Royall, P. G., Apr 2021, In: AAPS PharmSciTech. 22, 3, 105.Research output: Contribution to journal › Article › peer-review
Open Access6 Citations (Scopus) -
Stability of α-lactose monohydrate: The discovery of dehydration triggered solid-state epimerization
Alzoubi, T., Martin, G. P., Barlow, D. J. & Royall, P. G., 15 Jul 2021, In: INTERNATIONAL JOURNAL OF PHARMACEUTICS. 604, 120715.Research output: Contribution to journal › Article › peer-review
Open Access15 Citations (Scopus) -
Anti-counterfeiting DNA molecular tagging of pharmaceutical excipients: An evaluation of lactose containing tablets
Altamimi, M. J., Greenwood, J. C., Wolff, K., Hogan, M. E., Lakhani, A., Martin, G. P. & Royall, P. G., 25 Nov 2019, In: INTERNATIONAL JOURNAL OF PHARMACEUTICS. 571, 118656.Research output: Contribution to journal › Article › peer-review
13 Citations (Scopus) -
Delivered Lung Dose and Aerodynamic Particle Size Distribution of Salbutamol Pressurized Metered Dose Inhaler after Living under Patients' Realistic Retention Environments
Ammari, W. G., Khalil Mohammad, M., Tayyem, R. F., Martin, G. P. & Royall, P. G., 1 Dec 2019, In: Journal of Aerosol Medicine and Pulmonary Drug Delivery. 32, 6, p. 386-395 10 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus)
Projects
- 7 Finished
-
The production of spray-freeze dried particles for formulation development and inhalation using modified ink-jet printing technology
Royall, P. (Primary Investigator) & Martin, G. (Co-Investigator)
1/10/2009 → 31/03/2013
Project: Research
-
Engineering multi-component delivery systems for the controlled transcellular transport of inhalation therapeutics
Martin, G. (Primary Investigator), Murnane, D. (Primary Investigator) & Forbes, B. (Co-Investigator)
1/01/2009 → 31/12/2012
Project: Research
-
Investigating the dissolution of amorphous and semi-amorphous particles in simulated lung fluid
Martin, G. (Primary Investigator), Royall, P. (Primary Investigator) & Brown, M. (Co-Investigator)
EPSRC Engineering and Physical Sciences Research Council
1/01/2002 → 31/12/2004
Project: Research
-
The use of biodegradable microspheres for the pulmonary delivery of hydrophobic drugs.
Martin, G. (Primary Investigator) & Tee, S. K. (Co-Investigator)
1/10/2000 → 30/09/2002
Project: Research
-
Formulation of DNA/Lipid complexes
Martin, G. (Primary Investigator)
1/04/2000 → 21/08/2003
Project: Research